Form 4: BioLife Solutions Executive Sells Shares to Cover Tax Obligations

Todd Berard, Chief Marketing Officer of BioLife Solutions, sold 102 shares of common stock on February 12, 2025, to cover tax withholding obligations related to vesting restricted stock.

Summary

• On February 12, 2025, Todd Berard, the Chief Marketing Officer of BioLife Solutions Inc., sold 102 shares of the company's common stock.
• The sale was executed at a price of $26.54 per share.
• The transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted by Berard on February 8, 2021.
• The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
• Following the transaction, Berard directly owns 106,962 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

This is a routine Form 4 filing, indicating an insider transaction. Such filings are common and provide transparency into the trading activities of company executives. The sale appears to be for tax purposes, which is a typical reason for such transactions.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the stated reason for the sale.

Key Dates

Keywords

BioLife Solutions, BLFS, Todd Berard, insider trading, Form 4, stock sale, Rule 10b5-1, tax obligations, restricted stock, Chief Marketing Officer